Rebecca Gamble, PA
Physician Assistant · Indiana, PANPI 1245238252
Payments from drug & device makers
Across 302 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$930
- Neurocrine Biosciences, Inc.$305
- Otsuka America Pharmaceutical, Inc.$293
- Lundbeck LLC$277
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$240
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,69896%
- Education$2114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 85 | $1,194 |
| AbbVie | 58 | $930 |
| Neurocrine Biosciences, Inc. | 18 | $305 |
| Otsuka America Pharmaceutical, Inc. | 17 | $293 |
| Lundbeck LLC | 20 | $277 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $240 |
| Alkermes, Inc. | 12 | $206 |
| Novartis | 11 | $173 |
| Axsome Therapeutics, Inc. | 8 | $155 |
| Johnson & Johnson | 7 | $141 |
| Vanda Pharmaceuticals Inc. | 6 | $134 |
| Jazz Pharmaceuticals Inc. | 4 | $82 |
| SK Life Science, Inc. | 4 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Acadia Pharmaceuticals Inc | 3 | $56 |
| Eisai Inc. | 3 | $47 |
| Grifols USA, LLC | 2 | $43 |
| Amgen | 3 | $43 |
| Abbott | 2 | $36 |
| Sanofi | 2 | $36 |
| UCB, Inc. | 2 | $33 |
| AstraZeneca | 2 | $33 |
| Tanabe Pharma America, Inc. | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $20 |
| CSL Behring | 1 | $19 |
| Corium, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Averitas Pharma Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,909 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 16 | $238,335 |
| VraylarCariprazine Hcl | 58 | $83,430 |
| LatudaLurasidone Hcl | 24 | $38,493 |
| Abilify MaintenaAripiprazole | 12 | $33,661 |
| TrintellixVortioxetine Hydrobromide | 41 | $20,780 |
| Aripiprazole | 228 | $18,672 |
| RexultiBrexpiprazole | 12 | $18,254 |
| Escitalopram Oxalate | 785 | $10,086 |
| Duloxetine Hcl | 356 | $9,821 |
| Chlorpromazine Hcl | 16 | $8,886 |
| Sertraline Hcl | 376 | $7,164 |
| Clozapine | 121 | $6,842 |
| Bupropion XlBupropion Hcl | 318 | $6,234 |
| Quetiapine Fumarate | 411 | $5,507 |
| Fluphenazine Hcl | 12 | $5,455 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $1,194 | $238,33516 claims |
| AbbVieVraylar | $930 | $83,43058 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $293 | $51,91424 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $13 | $38,49324 claims |
| Lilly USA, LLCOlanzapine | $15 | $3,656210 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Indiana
- Stacy MoranIndiana$28K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.